In non-small cell lung cancer, NOX4 induces glycolysis through the ROS/PI3K/AKT pathway, and the NOX4 inhibitor in combination with a glycolysis inhibitor exert a synergistic inhibitory effect on cancer cells 15. This evidence concerns the gene NOX4 and non-small cell lung carcinoma.